Loading...
Large-bore catheters are necessary in percutaneous noncoronary interventions. To assess the risk for bleeding in such procedures, researchers analyzed data from a large U.S. inpatient database from 2012 through 2013: A total of 3223 patients with transcatheter aortic-valve replacement (TAVR), 12,633 with endovascular aneurysm repair, and 1816 with a percutaneous left ventricular assist device.
Overall, 17.7% had a hemorrhage (i.e., transfusion, hemorrhage or hematoma, or need for an intervention to control the bleeding event). Patients with bleeding had a significantly higher mortality than those without (adjusted odds ratio, 2.70), longer hospital stays (median, 7 vs. 2 days), and higher healthcare costs (median, US$48,663 vs. $29,968). Esp…